November 2, 2024

Infectious Disease Experts Warn: Brace for Yellow Fever Resurgence in U.S.

Transmittable illness professionals from Baylor College of Medicine and Stanford School of Medicine, in a publication in the New England Journal of Medicine, highlight the historic devastation triggered by yellow fever in between 1820 and 1905 and stress its prospective return. With the rise of similar diseases in the American South, experts advocate for improved monitoring, the development of antiviral drugs, vaccines, and innovative gene drive technology.
Professionals warn of a possible renewal of yellow fever in the American South, promoting for improved disease security, antiviral advancement, and innovative mosquito control procedures.
With the increase of mosquito-borne diseases, transmittable disease experts at Baylor College of Medicine and Stanford School of Medicine are warning of the possible re-emergence of yellow fever in the southern portion of the U.S. Their perspective piece on the virus prospective return was released on October 19 in the New England Journal of Medicine.
Historic Impact and Current Situation
Yellow fever is a mosquito-borne viral illness that annihilated southern U.S. cities in routine epidemics in New Orleans, Galveston, Memphis, and Charleston from 1820 to 1905, according to Dr. Peter Hotez, teacher and dean of the National School of Tropical Medicine at Baylor and co-director of the Texas Childrens Hospital Center for Vaccine Development and co-author of the paper. The virus is a flavivirus and arbovirus infection like dengue or Zika virus, but with much greater death. Yellow fever is sent by Aedes mosquitoes, which are common in the Caribbean and Latin America, as well as southern city locations like those in Texas and Florida.

With the rise of mosquito-borne illnesses, contagious illness experts at Baylor College of Medicine and Stanford School of Medicine are alerting of the possible re-emergence of yellow fever in the southern part of the U.S. Their point of view piece on the virus possible return was published on October 19 in the New England Journal of Medicine. Yellow fever is a mosquito-borne viral illness that annihilated southern U.S. cities in regular upsurges in New Orleans, Galveston, Memphis, and Charleston from 1820 to 1905, according to Dr. Peter Hotez, teacher and dean of the National School of Tropical Medicine at Baylor and co-director of the Texas Childrens Hospital Center for Vaccine Development and co-author of the paper.

” Weve seen an increase in mosquito-transmitted diseases in Texas and Florida, including malaria, chikungunya, zika, and dengue virus, now were likewise stressed over yellow fever given that it appears to be accelerating in tropical areas of Latin America such as Brazil and Venezuela,” Hotez said. “The consequences of a high death infection like yellow fever re-emerging in the southern U.S. would be profoundly destabilizing.”
Proposed Measures and Expert Insights
Experts propose broadening monitoring activities by boosting local health departments to fight mosquitoes and mosquito-borne diseases in addition to establishing antiviral drugs, vaccines, and brand-new gene drive innovation (completely altering insect genes through genetic engineering) for mosquito control efforts.
” The mosquitoes that spread yellow fever are here in the U.S. and conditions are increasingly beneficial for them as our world warms,” said Dr. Desiree LaBeaud, teacher of pediatrics-infectious illness at Stanford Medicine and co-author of the publication. “We need a comprehensive strategy to much better safeguard at-risk communities in the southern U.S. from mosquito-borne diseases.”
” One of the reasons we established National School of Tropical Medicine at Baylor was in recognition that tropical infections have actually ended up being a new regular due to a confluence of environment change, urbanization, and hardship on the U.S. Gulf Coast and Texas,” Hotez said.
Recommendation: “Yellow Jacks Potential Return to the American South” by Peter J. Hotez and Angelle Desiree LaBeaud, 13 October 2023, New England Journal of Medicine.DOI: 10.1056/ NEJMp2308420.